Article

The Candida Genome Database incorporates multiple Candida species: multispecies search and analysis tools with curated gene and protein information for Candida albicans and Candida glabrata

Department of Genetics, Stanford University Medical School, Stanford, CA 94305-5120, USA.
Nucleic Acids Research (Impact Factor: 9.11). 11/2011; 40(Database issue):D667-74. DOI: 10.1093/nar/gkr945
Source: PubMed

ABSTRACT

The Candida Genome Database (CGD, http://www .candidagenome.org/) is an internet-based resource that provides centralized access to genomic sequence data and manually curated functional information about genes and proteins of the fungal pathogen Candida albicans and other Candida species. As the scope of Candida research, and the number of sequenced strains and related species, has grown in recent years, the need for expanded genomic resources has also grown. To answer this need, CGD has expanded beyond storing data solely for C. albicans, now integrating data from multiple species. Herein we describe the incorporation of this multispecies information, which includes curated gene information and the reference sequence for C. glabrata, as well as orthology relationships that interconnect Locus Summary pages, allowing easy navigation between genes of C. albicans and C. glabrata. These orthology relationships are also used to predict GO annotations of their products. We have also added protein information pages that display domains, structural information and physicochemical properties; bibliographic pages highlighting important topic areas in Candida biology; and a laboratory strain lineage page that describes the lineage of commonly used laboratory strains. All of these data are freely available at http://www .candidagenome.org/. We welcome feedback from the research community at [email protected]
/* */

  • Source
    • "Wor4 homologs in fungal species were identified using the Fungal Genomes Search tool at the Saccharomyces Genome Database (Cherry et al. 2012) using the BLASTP tool (except for W. anomalus which used the TBLASTN tool) (Altschul et al. 1990). The protein sequence for the best hit in a given species was then compared to the C. albicans genome using the BLASTP tool at the Candida Genome Database (Inglis et al. 2012). A Wor4 homolog was considered to be present in a given species if both BLAST searches gave a hit with an E-value better than 1e-5 and if Wor4 was the highest scoring hit for the C. albicans genome. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The human fungal pathogen Candida albicans can switch between two cell types, "white" and "opaque," each of which is heritable through many cell divisions. Switching between these two cell types is regulated by six transcriptional regulators which form a highly interconnected circuit with multiple feedback loops. Here, we identify a seventh regulator of white-opaque switching, which we have named Wor4. We show that ectopic expression of Wor4 is sufficient to drive switching from the white to the opaque cell type and that deletion of Wor4 blocks switching from the white to the opaque cell type. A combination of ectopic expression and deletion experiments indicates that Wor4 is positioned upstream of Wor1 and that it is formally an activator of the opaque cell type. The combination of ectopic expression and deletion phenotypes for Wor4 is unique; none of the other six white-opaque regulators show this pattern. We determined the pattern of Wor4 binding across the genome by ChIP-seq and found it is highly correlated with that of Wor1 and Wor2, indicating that Wor4 is tightly integrated into the existing white-opaque regulatory circuit. We previously proposed that white-to-opaque switching relies on the activation of a complex circuit of feedback loops that remains excited through many cell divisions. The identification of a new, central regulator of white-opaque switching supports this idea by indicating that the white-opaque switching mechanism is considerably more complex than those controlling conventional, non-heritable patterns of gene expression.
    Preview · Article · Jan 2016 · G3-Genes Genomes Genetics
  • Source
    • "These interactions have been distilled from more than 45,000 publications covering 57 different organisms, including the budding yeast Saccharomyces cerevisiae, the fission yeast Schizosaccharomyces pombe, the yeast Candida albicans SC5314, the nematode Caenorhabditis elegans, the fruit fly Drosophila melanogaster, the mouse Mus musculus, the plant Arabidopsis thaliana, and Homo sapiens (Stark et al. 2011; Chatr-Aryamontri et al. 2013). BioGRID interaction data sets are shared with the respective model organism databases (Cherry et al. 2012; Inglis et al. 2012; Lamesch et al. 2012; Wood et al. 2012; Yook et al. 2012; Marygold et al. 2013), with other interaction databases (Luc and Tempst 2004; Razick et al. 2008; Chautard et al. 2009; Matthews et al. 2009; Cerami et al. 2011; Franceschini et al. 2013), and with metadatabases (Benson et al. 2004; Matthews et al. 2009). Complete coverage of the entire literature for S. cerevisiae and S. pombe, as well as for the model plant A. thaliana, is maintained through continuous monthly updates. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The Biological General Repository for Interaction Datasets (BioGRID) is a freely available public database that provides the biological and biomedical research communities with curated protein and genetic interaction data. Structured experimental evidence codes, an intuitive search interface, and visualization tools enable the discovery of individual gene, protein, or biological network function. BioGRID houses interaction data for the major model organism species including yeast, nematode, fly, zebrafish, mouse, and human with particular emphasis on the budding yeast Saccharomyces cerevisiae and the fission yeast Schizosaccharomyces pombe as pioneer eukaryotic models for network biology. BioGRID has achieved comprehensive curation coverage of the entire literature for these two major yeast models, which is actively maintained through monthly curation updates. As of September 2015, BioGRID houses approximately 335,400 biological interactions for budding yeast and approximately 67,800 interactions for fission yeast. BioGRID also supports an integrated post- translational modification (PTM) viewer that incorporates more than 20,100 yeast phosphorylation sites curated through its sister database, the PhosphoGRID.
    Preview · Article · Jan 2016
  • Source
    • "Thereisalsosubstantialevidencetosuggestthatfungican synthesizeandreleaseACh(Horiuchietal.,2003;Kawashima andFujii,2008).Indeed,sequencingoftheC.albicansgenome revealedthisorganismtopossessputativegenesfortheenzymes responsibleforAChsynthesis;cholineacetyltransferase(ChAT) andcarnitineacetyltransferase(CrAT;Inglisetal.,2012). However,theAChsynthesismachineryofC.albicansremainsto becharacterized.Furthermore,thebiologicalfunctionsoffungal derivedAChremaintobeelucidated. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Fungal infections have dramatically increased in the last decades in parallel with an increase of populations with impaired immunity, resulting from medical conditions such as cancer, transplantation, or other chronic diseases. Such opportunistic infections result from a complex relationship between fungi and host, and can range from self-limiting to chronic or life-threatening infections. Modern medicine, characterized by a wide use of biomedical devices, offers new niches for fungi to colonize and form biofilm communities. The capability of fungi to form biofilms is well documented and associated with increased drug tolerance and resistance. In addition, biofilm formation facilitates persistence in the host promoting a persistent inflammatory condition. With a limited availability of antifungals within our arsenal, new therapeutic approaches able to address both host and pathogenic factors that promote fungal disease progression, i.e., chronic inflammation and biofilm formation, could represent an advantage in the clinical setting. In this paper we discuss the antifungal properties of myriocin, fulvic acid, and acetylcholine in light of their already known anti-inflammatory activity and as candidate dual action therapeutics to treat opportunistic fungal infections.
    Full-text · Article · Oct 2015 · Frontiers in Microbiology
Show more